HIV medication access refers to the availability and affordability of antiretroviral drugs for individuals living with HIV, which is critical for managing the virus and preventing transmission. Ensuring access to these medications is essential for public health and individual well-being, particularly in the face of rising infection rates and persistent stigma surrounding the disease. The mechanism of HIV medication access involves several key steps: individuals must first undergo testing to confirm their HIV status, followed by the prescription of appropriate antiretroviral therapy based on their health needs. Ongoing monitoring and support from healthcare providers further enhance treatment adherence and effectiveness, ultimately leading to better health outcomes for those affected. Key benefits of ensuring HIV medication access include significantly improved health outcomes and enhanced quality of life for individuals living with HIV. Access to effective treatment reduces the viral load, which in turn lowers the risk of transmission to others. Programs like PEPFAR have played a crucial role in increasing access to HIV medications in low-resource settings, demonstrating the positive impact of accessible healthcare on global health. However, challenges remain, particularly regarding cost barriers and the detrimental effects of stigma and misinformation. High costs can be prohibitive for many seeking treatment, while societal stigma can discourage individuals from pursuing necessary healthcare. Addressing these obstacles is vital for achieving universal access to HIV medication and improving public health outcomes.